IBJNews

Medical oxygen plant in Plainfield closing; 130 to lose jobs

Back to TopCommentsE-mailPrintBookmark and Share

Cleveland-based Chart Industries Inc. will close its medical oxygen plant in Plainfield and merge production with existing operations in Georgia, resulting in the loss of 130 local jobs.

The company announced the closing on Monday and said it will take about a year to complete it.

Chart acquired the Plainfield manufacturing and customer service operations in November, as part of its purchase of Dublin, Ireland-based Covidien PLC’s liquid-oxygen therapy business.

“We have concluded that the consolidation of the manufacturing and customer service operations into our Canton, Georgia, campus is the most cost-effective solution to meet our customers’ needs,” said Steve Shaw, president of Chart’s biomedical group, in a written release.

The publicly traded Chart disclosed in company filings that the plant closing, severance pay for employees and the year remaining on the building’s lease will cost the company about $7 million.

Chart said it will provide assistance to help employees find new jobs.

The plant in Plainfield operates under Chart’s Caire Inc. division. Caire is the country’s largest provider of respiratory care products for the home health care market.

Its well-known Helios brand of medical and portable personal oxygen supplies is manufactured at the Plainfield facility.
 

ADVERTISEMENT

  • Big Loss
    Silence is deafening from Biocrossroads, Indiana Health Forum, Indy Partnership, & IEDC.

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT